Cellebrite appoints Capellas to board of directors, updates board positions

Cellebrite (CLBT) announced a series of Board updates to support the Company’s continued growth into 2025 and beyond. As previously detailed on November 6, 2024, Thomas Hogan has been appointed interim CEO to begin 2025 as part of a planned leadership transition. In conjunction with stepping into this position, Hogan remains on the Company’s Board of Directors and plans to revert to his position as chairman upon the eventual appointment of a new CEO. Adam Clammer, Managing Partner of True Wind Capital Management and Cellebrite’s current lead independent director, has assumed the duties of board chairman. Finally, Cellebrite announces that Michael D. Capellas has been appointed to Cellebrite’s Board of Directors as a Class II director. In addition, he will serve as the Board’s lead independent director, replacing the role vacated by Adam Clammer. All appointments were effective January 1, 2025